Tripathy R, Pande A
Pharm Res. 2025; 42(2):219-236.
PMID: 39953265
DOI: 10.1007/s11095-025-03829-z.
Ji Q, Kowalski K, Golenberg E, Chung S, Barker N, Bickford W
Plants (Basel). 2025; 14(3).
PMID: 39943020
PMC: 11820330.
DOI: 10.3390/plants14030458.
Leckie J, Rodriguez S, Krahn M, Yokota T
Cells. 2025; 14(3).
PMID: 39936969
PMC: 11817064.
DOI: 10.3390/cells14030177.
Gray M, de Janon A, Seeler M, Heller W, Panoskaltsis N, Mantalaris A
ACS Omega. 2025; 10(3):2628-2639.
PMID: 39895718
PMC: 11780410.
DOI: 10.1021/acsomega.4c07666.
Feng Y, Su C, Mao G, Sun B, Cai Y, Dai J
Life Med. 2025; 3(1):lnae010.
PMID: 39872399
PMC: 11749639.
DOI: 10.1093/lifemedi/lnae010.
Small Interfering RNA Therapy for the Management and Prevention of Hypertension.
Ren L, Danser A
Curr Hypertens Rep. 2025; 27(1):5.
PMID: 39808369
PMC: 11732957.
DOI: 10.1007/s11906-025-01325-8.
The 'genetic zipper' method offers a cost-effective solution for aphid control.
Oberemok V, Puzanova Y, Galchinsky N
Front Insect Sci. 2024; 4:1467221.
PMID: 39726916
PMC: 11670321.
DOI: 10.3389/finsc.2024.1467221.
Application of 4'--α-aminoethoxy-2'--methyl-5-propynyl-uridine for antisense therapeutics.
Zhou Y, Sato H, Kawade M, Yamagishi K, Ueno Y
RSC Adv. 2024; 14(53):39148-39162.
PMID: 39664244
PMC: 11632595.
DOI: 10.1039/d4ra06376g.
Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma.
Khuu A, Verreault M, Colin P, Tran H, Idbaih A
Cells. 2024; 13(22).
PMID: 39594617
PMC: 11592788.
DOI: 10.3390/cells13221869.
Regulation of TAR DNA binding protein 43 (TDP-43) homeostasis by cytosolic DNA accumulation.
Yang C, Leifer C, Lammerding J, Hu F
J Biol Chem. 2024; 300(12):107999.
PMID: 39551138
PMC: 11719319.
DOI: 10.1016/j.jbc.2024.107999.
Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery.
Yadav S, Dhuri K, Gamiotea-Turro D, Cormier M, Patel V, Yadawa A
Mol Ther Nucleic Acids. 2024; 35(4):102355.
PMID: 39507400
PMC: 11539414.
DOI: 10.1016/j.omtn.2024.102355.
Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials.
Ogieuhi I, Callender K, Odukudu G, Obi E, Muzofa K, Babalola A
High Blood Press Cardiovasc Prev. 2024; 32(1):33-47.
PMID: 39476283
DOI: 10.1007/s40292-024-00682-w.
Chemical strategies for antisense antibiotics.
Pals M, Lindberg A, Velema W
Chem Soc Rev. 2024; 53(23):11303-11320.
PMID: 39436264
PMC: 11495246.
DOI: 10.1039/d4cs00238e.
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy.
Lee M, Lee M, Song Y, Kim S, Park N
Molecules. 2024; 29(19).
PMID: 39407665
PMC: 11477775.
DOI: 10.3390/molecules29194737.
Emerging RNAi Therapies to Treat Hypertension.
Daga P, Singh G, Menon T, Sztukowska M, Kalra D
Mol Diagn Ther. 2024; 29(1):25-41.
PMID: 39400663
DOI: 10.1007/s40291-024-00747-5.
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside.
Cakan E, Lara O, Szymanowska A, Bayraktar E, Chavez-Reyes A, Lopez-Berestein G
Cancers (Basel). 2024; 16(17).
PMID: 39272802
PMC: 11394571.
DOI: 10.3390/cancers16172940.
Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape.
Beck S, Yokota T
Int J Mol Sci. 2024; 25(16).
PMID: 39201751
PMC: 11354670.
DOI: 10.3390/ijms25169065.
Novel Therapeutic Horizons: Targeting in Parkinson's Disease.
Caramiello A, Pirota V
Biomolecules. 2024; 14(8).
PMID: 39199337
PMC: 11352499.
DOI: 10.3390/biom14080949.
Structural Unfolding of G-Quadruplexes: From Small Molecules to Antisense Strategies.
Fracchioni G, Vailati S, Grazioli M, Pirota V
Molecules. 2024; 29(15).
PMID: 39124893
PMC: 11314335.
DOI: 10.3390/molecules29153488.
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.
Murphy A, Wilton S, Aung-Htut M, McIntosh C
Front Mol Neurosci. 2024; 17:1391564.
PMID: 39114642
PMC: 11303307.
DOI: 10.3389/fnmol.2024.1391564.
